Direct reporting network in Beijing in April 12th (Southern Daily) in recent years, with the increase in China's population, accelerated aging, health care reform policy innovation, health care field has become the industry's capital favored. Based on large data precision medical services will provide more accurate support for clinical decision makers and hospitals, bioinformatics, big data analysis and other related technical fields or will become the focus of attention of the capital.

The huge investment with the bat and other Internet giants have admission, Lilac Garden, spring mobile health medical internet project attracted the eyes of many people. In fact, in addition to the public more familiar with the community of internet medical related areas, as the cornerstone of the medical health industry, bio pharmaceutical technology and products, the same is the number of wind investment in the hot project. Because of the sophisticated technical content, these projects tend to have higher capital requirements, and once the listing is successful, its returns are also very rich.

High end technology research capital demand

Influx of domestic capital in the field of health care is not new, but with the level of domestic research continues to improve, the demand for funds in the field of high-end technology research is bringing more and more investment opportunities. Such as precision medical, cancer drugs, blood system diseases drugs may in the future to obtain a breakthrough progress of technology, biological 3D printing interdisciplinary technology there are great imagination, and thus obtain capital intensive attention.

Recently held the 7th China Medical Industry Forum, tat gene, deputy chief engineer, Cheng said that healthcare industry has a research relies on high technology, of talent dependent and require high capital input characteristics. Domestic pharmaceutical industry is highly fragmented, statistics, there were 3.1 million businesses, but the total value of still less than a Merck & company value. This also means that the domestic pharmaceutical industry space is huge, the future of enterprises through rapid growth and mergers and acquisitions, a lot of opportunities to occupy a greater market share.

Cheng Gang said that the development of bio pharmaceutical industry in the past, different ways. Domestic company's boss is often the originators of the enterprise, technological invention or the earliest investors, in charge of the enterprise from the original research and development to appear on the market to the industrialization of the entire process, and foreign bio pharmaceutical technology or product is the development phase. Throughout the process, no one from the beginning to the end, each person only do their own professional things.

"Is usually the original technology in university or research institute by scientists do, finish the later to find the angel investment, put the technology into products, the scientists put the products sell to get millions of dollars back to study." Cheng Gang said that the second stages of foreign countries are generally done by small companies to do product research, with the wind investment funds will be new technology, new product industrialization, and even the completion of the supervision of the Department of product registration.

"After the completion of this stage, most companies will choose to sell products to large multinational Medicines Co." Cheng Gang introduced, large Medicines Co can use two markets, with the global capital to achieve product marketing promotion and sales.

Cheng Gang believes that in the face of huge capital needs and complex market environment, the health care enterprise managers can not only focus on R & D and sales, but also to consider the integration of technology and capital. Dedicated to biological research of 3D Printing Technology Guangzhou Maipu company chairman Yu Yu Yuan in Chinese medical industry forum also to Southern Daily reporter said in the future the company plans to appear on the market, because the capital of enterprise development has promoting effect.